The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
AIRM and Universal Cells have entered into an exclusive worldwide license agreement to research, develop and commercialize a novel cell therapy for an...
read more
Roivant Sciences today announced that it has entered into a development partnership with AstraZeneca for a deprioritized investigational drug in an ...
read more
DURECT reported that the Phase 3 clinical trial for POSIMIR did not meet its primary efficacy endpoint of reduction in pain on movement over the first...
read more
Thursday, October 19, 2017
Novo Nordisk announced the EMDAC of the FDA voted 16-0, supporting the approval of once-weekly semaglutide to improve glycemic control in adults with ...
read more
Wednesday, October 18, 2017
FluGen has been awarded a grant of $14.4 million through the DOD’s Congressionally Directed Medical Research Programs PRMRP mechanism to conduct ...
read more
Wednesday, October 18, 2017
Spyryx Biosciences announced the first patient was dosed in the HOPE-1 study, a multinational Phase 2 clinical trial for its lead compound, SPX-101 in...
read more
Wednesday, October 18, 2017
Novartis announced long-term study results supporting the positive safety and efficacy of Promacta in adults with chronic/persistent ITP.
read more
Tuesday, October 17, 2017
Cadent Therapeutics has earned a milestone payment for the initiation of a Phase 1 clinical study of a subtype selective NMDA receptor negative ...
read more
Tuesday, October 17, 2017
Eagle Pharmaceuticals has been issued a new patent related to its RYANODEX formulation by the United States Patent and Trademark Office.
read more
BrainStorm announced that the first patients have been enrolled in the Phase 3 clinical trial of NurOwn for the treatment of ALS.
read more
Regeneron and Sanofi announced positive results from a Phase 2 investigational study of dupilumab in adults with active moderate-to-severe ...
read more
Halozyme Therapeutics announced initiation of a clinical trial evaluating its investigational new drug PEGPH20 with atezolizumab, an anti-PDL1 cancer ...
read more
SU2C has awarded 10 Catalyst clinical trial projects in which researchers from more than 30 institutions collaborate across academic and corporate ...
read more
Prometic Life Sciences announced the FDA has accepted its BLA for its plasminogen replacement therapy Ryplazim.
read more
Prometic Life Sciences announced the FDA has accepted its BLA for its plasminogen replacement therapy Ryplazim.
read more